Ukraine vs Georgia vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 91% | 90% |
| 2023 | 92% | 95% |
| 2022 | 74% | 90% |
| 2021 | 89% | 90% |
| 2020 | 85% | 91% |
| 2019 | 93% | 99% |
| 2018 | 91% | 98% |
| 2017 | 86% | 95% |
| 2016 | 42% | 93% |
| 2015 | 56% | 96% |
| 2014 | 56% | 92% |
| 2013 | 79% | 97% |
| 2012 | 79% | 93% |
| 2011 | 67% | 91% |
| 2010 | 56% | 94% |
| 2009 | 75% | 83% |
| 2008 | 94% | 97% |
| 2007 | 97% | 97% |
| 2006 | 98% | 96% |
| 2005 | 96% | 90% |
| 2004 | 99% | 86% |
| 2003 | 99% | 76% |
| 2002 | 99% | 75% |
| 2001 | 99% | 74% |
| 2000 | 99% | 73% |
| 1999 | 99% | 76% |
| 1998 | 96% | 73% |
| 1997 | 97% | 69% |
| 1996 | 92% | 65% |
| 1995 | 97% | 61% |
| 1994 | 96% | 63% |
| 1993 | 94% | 61% |
| 1992 | 90% | 16% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 88% | 86% |
| 2023 | 83% | 88% |
| 2022 | 73% | 85% |
| 2021 | 78% | 85% |
| 2020 | 81% | 88% |
| 2019 | 80% | 94% |
| 2018 | 69% | 93% |
| 2017 | 50% | 91% |
| 2016 | 19% | 92% |
| 2015 | 23% | 94% |
| 2014 | 23% | 91% |
| 2013 | 76% | 93% |
| 2012 | 76% | 92% |
| 2011 | 50% | 94% |
| 2010 | 52% | 92% |
| 2009 | 71% | 88% |
| 2008 | 90% | 92% |
| 2007 | 98% | 98% |
| 2006 | 98% | 88% |
| 2005 | 96% | 82% |
| 2004 | 99% | 78% |
| 2003 | 97% | 75% |
| 2002 | 99% | 84% |
| 2001 | 99% | 87% |
| 2000 | 99% | 80% |
| 1999 | 99% | 84% |
| 1998 | 98% | 80% |
| 1997 | 99% | 80% |
| 1996 | 99% | 80% |
| 1995 | 98% | 79% |
| 1994 | 97% | 58% |
| 1993 | 93% | 54% |
| 1992 | 88% | 58% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 88% | 90% |
| 2023 | 79% | 93% |
| 2022 | 62% | 85% |
| 2021 | 77% | 85% |
| 2020 | 81% | 88% |
| 2019 | 77% | 94% |
| 2018 | 67% | 93% |
| 2017 | 52% | 91% |
| 2016 | 26% | 92% |
| 2015 | 22% | 94% |
| 2014 | 22% | 91% |
| 2013 | 46% | 96% |
| 2012 | 46% | 92% |
| 2011 | 21% | 89% |
| 2010 | 48% | 95% |
| 2009 | 66% | 54% |
| 2008 | 84% | 89% |
| 2007 | 92% | 94% |
| 2006 | 96% | 84% |
| 2005 | 97% | 79% |
| 2004 | 98% | 64% |
| 2003 | 77% | 48% |
| 2002 | 48% | 51% |
| 2001 | 7% | 61% |
| 2000 | 4% | 55% |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 91% of children aged 12–23 months in Ukraine and 90% in Georgia: 1 percentage point more in Ukraine. The third DTP dose reaches 88% in Ukraine and 86% in Georgia, 2 points more in Ukraine. The third hepatitis B dose reaches 88% in Ukraine and 90% in Georgia, 2 points more in Georgia. In 1992, the first measles dose reached 90% in Ukraine and 16% in Georgia, 74 percentage points more in Ukraine.
Ukraine vs Georgia: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 91% (2024) | 90% (2024) |
| DTP3 | 88% (2024) | 86% (2024) |
| HepB3 | 88% (2024) | 90% (2024) |
Ukraine and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Georgia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Ukraine and its seven neighbors, the latest coverage of the first measles dose is highest in Hungary, at 99%, and lowest in Romania, at 78%; of Georgia and its four neighbors, the latest coverage of the first measles dose is highest in Russia, at 97%, and lowest in Azerbaijan, at 71%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.